Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.

about

Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study.

Item

http://www.wikidata.org/entity/Q54974804

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Partial stereotactic ablative ...... cancer: a retrospective study.

@en

Partial stereotactic ablative ...... cancer: a retrospective study.

@nl

type

Item

label

Partial stereotactic ablative ...... cancer: a retrospective study.

@en

Partial stereotactic ablative ...... cancer: a retrospective study.

@nl

prefLabel

Partial stereotactic ablative ...... cancer: a retrospective study.

@en

Partial stereotactic ablative ...... cancer: a retrospective study.

@nl

P1476

Partial stereotactic ablative ...... cancer: a retrospective study.

@en

P2093

Bo Zhao

http://www.w3.org/2001/XMLSchema#string

Jia-Yan Chen

http://www.w3.org/2001/XMLSchema#string

Meng-Meng Su

http://www.w3.org/2001/XMLSchema#string

Ming Cui

http://www.w3.org/2001/XMLSchema#string

Ming-Wei Ma

http://www.w3.org/2001/XMLSchema#string

Mu Xie

http://www.w3.org/2001/XMLSchema#string

Qing Liu

http://www.w3.org/2001/XMLSchema#string

Shang-Bin Qin

http://www.w3.org/2001/XMLSchema#string

Xian-Shu Gao

http://www.w3.org/2001/XMLSchema#string

Xiao-Bin Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Is surgery still the optimal treatment for stage I non-small cell lung cancer?

The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant

Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.

Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.

Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Conformity index: a review.

Indirect Tumor Cell Death After High-Dose Hypofractionated Irradiation: Implications for Stereotactic Body Radiation Therapy and Stereotactic Radiation Surgery.

Dose escalation with stereotactic body radiation therapy boost for locally advanced non small cell lung cancer.

P304

2571-2579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S159538

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yun Bai

P577

2018-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29780250

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5951217

http://www.w3.org/2001/XMLSchema#string